Navigation Links
UAB will carry out an in-depth study of the effects olive oil has on the prevention of breast cancer

Ana Ripoll, Rector of Universitat Autnoma de Barcelona (UAB), and Pedro Barato, President of "Organizacin Interprofesional del Aceite de Oliva Espaol", signed a research agreement to carry out an in depth study on how the intake of olive oil can work towards preventing and fighting against breast cancer. The Multidisciplinary Group on Breast Cancer Research (GMECM), directed by Dr Eduard Escrich, lecturer of the Department of Cell Biology, Physiology and Immunology, will be working on this research project during the next five years. GMECM has demonstrated in previous researches that a moderate intake of virgin olive oil slows down the spreading of this cancer.

Researchers at GMECM aim to determine the possible activity of common components of the human diet with the objective of formulating scientific opinions on the health of the population or levels of risk, all within the field of breast cancer prevention. Among the results obtained until now researchers highlight the fact that a moderate intake of virgin olive oil can slow down the spreading of this cancer due to the action of mechanisms which counterattack the possible harmful effects of fats, while an excessive intake of seed oils has damaging effects.

In the study, which will begin this coming year, researchers will continue to study the effects olive oil can have on this type of cancer, with experimental studies and with human cell lines and samples. Among the research studies to be carried out, some of the most prominent focus on the effects fats and oils can have on mammary tumours, and especially those of extra virgin olive oil, and an analysis of the molecular changes found in these tumours in all of the genome and in the specific genes implicated in this pathology.

It is foreseen that the agreement between UAB and "Organizacin Interprofesional del Aceite de Oliva Espaol" will form part of a collaboration framework between the two former entities and the Departments of Agriculture, Food and Rural Action, and of Health of the Catalan Government. Under this agreement, GMECM receives the support of another entity of the olive oil sector, and institutional recognition for its research activities. It has recently received support from entities such as the Ministry for Science, the Catalan Government, the "Patrimonio Comunal Olivarero" Foundation and the Olive Oil Agency belonging to the Spanish Ministry for the Environment and Rural and Marine Regions.

The research tasks of GMECM have earned it numerous recognitions in the past few years, including prizes from the Medical Sciences and Health Academy of Catalonia and the Balearic Islands, the Spanish Society of Senology and Mammary Pathology, and those awarded recently to Dr Escrich which include the International Award of the "Santiago Dexeus Font" Foundation for his professional trajectory in the field of research in Mastology, the Picudo Award for his research into olive oil and health, and the FECOES National Nutrition Prize for his contributions to the studies into the effects of nutrition on breast cancer. Dr Escrich was also made member of the Mare de Du de l'Olivera Brotherhood of the Santa Maria del Mar Basilica of Barcelona.


Contact: Mara Jess Delgado
Universitat Autonoma de Barcelona

Related medicine news :

1. Florida Whole Foods Stores to Carry Dr. Lawrence Shapiro's Help Hair Shake
2. QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators
3. Miriam Margolyes to Carry Out DLF's 40th Anniversary Appeal on Radio 4 on 4th October
4. Medications That Lower Breast Cancer Risk Carry Other Dangers
5. 1 in 4 nursing home residents carry MRSA
6. Third of EMS Stethoscopes Carry MRSA Bacterium
7. Third of EMS Stethoscopes Carry MRSA Virus
8. Spinal taps carry higher risks for infants and elderly, study shows
9. Tiniest Babies Carry Biggest Costs
10. Teens From Smoke-Free Homes Carry on Tradition
11. Chronic Pain Patients Now Have Hope With Carryover Pain Relief Provided By Repeated Interferential Treatments
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... In an ... restrictions and variables that determine which patients are or are not eligible for bariatric ... have a BMI over 40, are more than 100 pounds overweight, or have a ...
(Date:11/24/2015)... UT (PRWEB) , ... November 24, 2015 , ... It ... Magazine. For a business, it is critical that the first impression be positive and ... they are not likely to buy anything or want to return. They will also ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... gather to share their knowledge and experiences at a live taping of the ... Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Aided by ... today announced an innovative study designed to yield insights into how to detect and ... of biomarkers for pancreatic cancer from small, non-coding RNA molecules (ncRNA), genetic material that ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir Grout of Baltimore is ... certification. The award recognizes good companies for excellence in service and a commitment ... and hard surface restoration company earned this recognition after a thorough review by ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
(Date:11/24/2015)... YORK , Nov. 24, 2015 iRhythm Technologies, ... advancing cardiac care, today announced that it will participate in the ... Hotel in New York, NY . ... present on Tuesday December 1, 2015 at 8:50am ET. ... . --> . ...
(Date:11/24/2015)... uptake of recently approved and pipeline premium products for Type 1 Diabetes ... says GBI Research . --> The ... Mellitus (T1DM), will be a key driver of market growth to 2021, ... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . Type ...
Breaking Medicine Technology: